Sponsor

Kamada Ltd.

2 Holzman Haim Street, 7670402

About the sponsor

Kamada Ltd. is engaged in clinical research for adults with congenital alpha-1 antitrypsin deficiency, with attention to patients who have moderate to severe airflow limitation and reduced pulmonary function.

Congenital alpha-1 antitrypsin deficiency
Adult respiratory disease
Pulmonary function impairment

The sponsor’s research focus in this area centers on chronic lung disease associated with inherited protein deficiency.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Not recruiting

Investigational

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Human Alpha1-Proteinase Inhibitor
Sponsor:Kamada Ltd.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

Ongoing trials

1 clinical trial

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.